CTKB - Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference | Benzinga
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 2023 Cantor Fitzgerald Global Healthcare Conference in New York, New York.
Cytek management is scheduled to participate in a fireside chat on Wednesday, September 27th at 1:15 p.m. Eastern Time / 10:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at: investors.cytekbio.com.
About Cytek Biosciences, Inc.
Cytek Biosciences (NASDAQ:CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ ...